Results 181 to 190 of about 1,458,706 (335)

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Biogenic amorphous calcium phosphate: a sustainable alternative for dentin remineralization. [PDF]

BMC Oral Health
Madhubala MM, Nayantara GS, Jayasree R, Locs J, Mahalaxmi S.   +4 more
europepmc   +1 more source

Assessment of Heavy-Metal Leaching from Recycled Concrete Debris and Bottom Ash as Sustainable Alternatives for Railway Ballast in Tropical Environments

Youventharan Duraisamy, Jeevithan Kirushna Moorthi, Rokiah Othman, Mohd Arif Sulaiman   +3 more
openalex   +1 more source

Short Sea Shipping as a Sustainable Modal Alternative: Qualitative and Quantitative Perspectives [PDF]

Michael J. Izdebski, Lokesh Kumar Kalahasthi, Andrés Regal-Ludowieg, José Holguín‐Veras   +3 more
openalex   +1 more source

Preferences for post‐traumatic osteoarthritis prevention strategies in individuals with anterior cruciate ligament injury

Arthritis Care &Research, Accepted Article.
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy, Lily Waddell, Adam Easterbrook, Jeffrey N. Katz, Cale Jacobs, Morgan Jones, Faith Selzer, Elena Losina, Liana Fraenkel, Nick Bansback   +9 more
wiley   +1 more source

Vitrimer as a Sustainable Alternative to Traditional Thermoset: Recent Progress and Future Prospective. [PDF]

ACS Polym Au
Ye G, Wang C, Guo Y, Yang Q, Huo S.
europepmc   +1 more source

Exploring Patients’ Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart, Laurène Norberciak, Pascal Richette, Pierre Robinet, Aurore Pacaud, Gauthier Marchasson, Thibault Rabin, Hélène Luraschi, Pierre Maciejasz, Anne‐France Georgel, Augustin Latourte, Hang‐Korng Ea, Sébastien Ottaviani, Charlotte Jauffret, Vincent Ducoulombier   +14 more
wiley   +1 more source

Cardoon cake as a sustainable alternative ingredient in broiler feeding. [PDF]

Ital J Anim Sci
Mannelli F, Scicutella F, Conte G, Daghio M, Viti C, Galigani I, Toni E, Miele A, Brajon G, Nannucci L, Buccioni A.   +10 more
europepmc   +1 more source

Microcrystalline Cellulose: A Sustainable Alternative to Combat Heavy Metal Pollution in Soil

Lazar Arun, Evangelin Ramani Sujatha
openalex   +1 more source

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis–Associated Uveitis or Chronic Anterior Antinuclear Antibody–Positive Uveitis

Arthritis Care &Research, EarlyView.
Objective To evaluate the efficacy and safety of baricitinib in pediatric patients with active juvenile idiopathic arthritis–associated uveitis (JIA‐U) or chronic anterior antinuclear antibody–positive uveitis, who had an inadequate response to methotrexate (MTX) or biologic disease‐modifying antirheumatic drugs (bDMARDs).
Athimalaipet V. Ramanan, Catherine M. Guly, Gabriele Simonini, Stuart Y. Keller, Priyanka Sen, Thorsten Holzkaemper, Joana Araújo, Pierre Quartier   +7 more
wiley   +1 more source